Literature DB >> 15904995

The effects of APOE and tau gene variability on risk of frontotemporal dementia.

L Bernardi1, R G Maletta, C Tomaino, N Smirne, M Di Natale, M Perri, T Longo, R Colao, S A M Curcio, G Puccio, M Mirabelli, T Kawarai, E Rogaeva, P H St George Hyslop, G Passarino, G De Benedictis, A C Bruni.   

Abstract

Frontotemporal dementia (FTD) is a complex dementing syndrome whose genetic/non genetic risk factors are mostly unknown. Aim of the present work was to investigate whether APOE and/or tau gene variability does affect the risk of FTD. A sample of FTD cases (sporadic: n = 54; familial: n = 46, one subject per family) was collected in a genetically homogeneous population (Calabria, southern Italy) and analyzed in comparison with an age- and sex-matched control group (n = 180) extracted from the same population. Logistic regression analysis showed that APOE gene variability affects the probability of disease, with allele epsilon4 increasing (exp(beta1) = 2.68 with [1.51-4.76] 95% confidence interval; p = 0.001) and allele epsilon2 decreasing (exp(beta1) = 0.28 with [0.12-0.66] 95% confidence interval; p = 0.003) the risk of FTD. On the contrary, tau gene variability was ineffectual (exp(beta1) non significantly different from 1 for either H1 or H2 haplotypes), although a small effect was observed by the H1 haplotype in increasing the protective effect of the epsilon2 allele (p = 0.007).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 15904995     DOI: 10.1016/j.neurobiolaging.2005.03.008

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  27 in total

Review 1.  Frontotemporal lobar degeneration: current knowledge and future challenges.

Authors:  Chiara Cerami; Elio Scarpini; Stefano F Cappa; Daniela Galimberti
Journal:  J Neurol       Date:  2012-04-25       Impact factor: 4.849

Review 2.  Apolipoprotein E and Alzheimer's disease: the influence of apolipoprotein E on amyloid-β and other amyloidogenic proteins.

Authors:  Tien-Phat V Huynh; Albert A Davis; Jason D Ulrich; David M Holtzman
Journal:  J Lipid Res       Date:  2017-02-27       Impact factor: 5.922

3.  Perspectives on ethnic and racial disparities in Alzheimer's disease and related dementias: Update and areas of immediate need.

Authors:  Ganesh M Babulal; Yakeel T Quiroz; Benedict C Albensi; Eider Arenaza-Urquijo; Arlene J Astell; Claudio Babiloni; Alex Bahar-Fuchs; Joanne Bell; Gene L Bowman; Adam M Brickman; Gaël Chételat; Carrie Ciro; Ann D Cohen; Peggye Dilworth-Anderson; Hiroko H Dodge; Simone Dreux; Steven Edland; Anna Esbensen; Lisbeth Evered; Michael Ewers; Keith N Fargo; Juan Fortea; Hector Gonzalez; Deborah R Gustafson; Elizabeth Head; James A Hendrix; Scott M Hofer; Leigh A Johnson; Roos Jutten; Kerry Kilborn; Krista L Lanctôt; Jennifer J Manly; Ralph N Martins; Michelle M Mielke; Martha Clare Morris; Melissa E Murray; Esther S Oh; Mario A Parra; Robert A Rissman; Catherine M Roe; Octavio A Santos; Nikolaos Scarmeas; Lon S Schneider; Nicole Schupf; Sietske Sikkes; Heather M Snyder; Hamid R Sohrabi; Yaakov Stern; Andre Strydom; Yi Tang; Graciela Muniz Terrera; Charlotte Teunissen; Debora Melo van Lent; Michael Weinborn; Linda Wesselman; Donna M Wilcock; Henrik Zetterberg; Sid E O'Bryant
Journal:  Alzheimers Dement       Date:  2018-12-13       Impact factor: 21.566

4.  Homozygous carriers of APP A713T mutation in an autosomal dominant Alzheimer disease family.

Authors:  Maria E Conidi; Livia Bernardi; Gianfranco Puccio; Nicoletta Smirne; Maria G Muraca; Sabrina A M Curcio; Rosanna Colao; Paola Piscopo; Maura Gallo; Maria Anfossi; Francesca Frangipane; Alessandra Clodomiro; Maria Mirabelli; Franca Vasso; Chiara Cupidi; Giusi Torchia; Raffaele Di Lorenzo; Paola Mandich; Annamaria Confaloni; Raffaele G Maletta; Amalia C Bruni
Journal:  Neurology       Date:  2015-05-06       Impact factor: 9.910

5.  APOE ε2 and ε4 influence the susceptibility for Alzheimer's disease but not other dementias.

Authors:  Carlo Lovati; Daniela Galimberti; Diego Albani; Pierluigi Bertora; Eliana Venturelli; Giuliana Cislaghi; Ilaria Guidi; Chiara Fenoglio; Francesca Cortini; Francesca Clerici; Dario Finazzi; Gianluigi Forloni; Elio Scarpini; Claudio Mariani
Journal:  Int J Mol Epidemiol Genet       Date:  2010-04-05

6.  [Frontotemporal dementia in association with a family history of dementia and ApoE polymorphism].

Authors:  M Zintl; M Petkov; G Schmitz; G Hajak; H-H Klünemann
Journal:  Nervenarzt       Date:  2010-01       Impact factor: 1.214

7.  Novel MAPT Val75Ala mutation and PSEN2 Arg62Hys in two siblings with frontotemporal dementia.

Authors:  Maura Gallo; Carmine Tomaino; Gianfranco Puccio; Francesca Frangipane; Sabrina A M Curcio; Livia Bernardi; Silvana Geracitano; Maria Anfossi; Maria Mirabelli; Rosanna Colao; Franca Vasso; Nicoletta Smirne; Raffaele G Maletta; Amalia Cecilia Bruni
Journal:  Neurol Sci       Date:  2009-09-19       Impact factor: 3.307

8.  Unusually long duration and delayed penetrance in a family with FTD and mutation in MAPT (V337M).

Authors:  Kimiko Domoto-Reilly; Marie Y Davis; C Dirk Keene; Thomas D Bird
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2016-03-16       Impact factor: 3.568

9.  Genetically altering Abeta distribution from the brain to the vasculature ameliorates tau pathology.

Authors:  Salvatore Oddo; Antonella Caccamo; David Cheng; Frank M LaFerla
Journal:  Brain Pathol       Date:  2008-07-24       Impact factor: 6.508

10.  Novel progranulin mutations with reduced serum-progranulin levels in frontotemporal lobar degeneration.

Authors:  Huei-Hsin Chiang; Charlotte Forsell; Lena Lilius; Linn Öijerstedt; Steinunn Thordardottir; Krishnan Shanmugarajan; Marie Westerlund; Inger Nennesmo; Håkan Thonberg; Caroline Graff
Journal:  Eur J Hum Genet       Date:  2013-03-06       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.